CEAClaudin 18.2mesothelinNKG2D(L)GIMsolid tumorsGastrointestinal malignancies
….92% of investigations. Claudin 18.2, NKG2D(L), mesothelin, and CEA emerged as the most frequently targeted antigens. Autologous th…
2articles mentioning drugs
4drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Claudin 18.2 ×
Claudin 18.2
This drug is selected. Its supporting articles are shown below.
Articles mentioning Claudin 18.2
2 articles · page 1 of 1Claudin 18.2-directed therapiesClaudin 18.2gastric and gastro-oesophageal junction adenocarcinomasClaudin 18.2-directed therapies
… cut-offs, clarify prognostic value and optimise integration of Claudin 18.2-directed therapies into routine care.…